Insiders / Coughlin Timothy / Activity

Activity — Coughlin Timothy

13 moves.

BiggestBiggest buysBiggest sellsHighest impact
InsidersInstitutions
DateActionCompanyValueShares ΔPosition afterImpact
Jun 12, 2026SellTVTX
Travere Therapeutics, Inc.
Common Stock
$500.7K-10K
-15.09%
56,250
0.06% of shares
medium
Jun 12, 2026ExerciseTVTX
Travere Therapeutics, Inc.
Common Stock
$265.2K+10K
+17.78%
66,250
0.07% of shares
low
May 15, 2026SellTVTX
Travere Therapeutics, Inc.
Common Stock
$141.3K-3K
-5.86%
52,250
0.06% of shares
medium
Jun 3, 2026OtherADCT
ADC Therapeutics SA
Common Shares
$38.8K-13K
-14.82%
72,400
0.06% of shares
low
Jun 9, 2026GrantVIR
Vir Biotechnology, Inc.
Common Stock
$0+8K
+100.00%
16,000
<0.01% of shares
low
Jun 9, 2026GrantVIR
Vir Biotechnology, Inc.
Common Stock
$0+8K
8,000
<0.01% of shares
low
Jun 1, 2026GrantADCT
ADC Therapeutics SA
Common Shares
$0+45K
+112.50%
85,000
0.07% of shares
low
May 19, 2026GrantTVTX
Travere Therapeutics, Inc.
Common Stock
$0+4K
+7.66%
56,250
0.06% of shares
low
Jun 12, 2026ExerciseTVTX
Travere Therapeutics, Inc.
Stock Option (Right to Buy)
—-10K
-100.00%
0
0.00% of shares
low
Jun 9, 2026GrantVIR
Vir Biotechnology, Inc.
Stock Option (Right to Buy)
—+16K
16,000
<0.01% of shares
low
Jun 9, 2026GrantVIR
Vir Biotechnology, Inc.
Stock Option (Right to Buy)
—+16K
16,000
<0.01% of shares
low
May 19, 2026GrantTVTX
Travere Therapeutics, Inc.
Stock option (right to buy)
—+12K
12,000
0.01% of shares
low
May 11, 2026GrantATYR
Atyr Pharma Inc
Stock Option (right to buy)
—+50K
50,000
0.05% of shares
low
← PrevPage 1 of 1Next →